Outlook Therapeutics, Inc. Annual Depreciation in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Outlook Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2020 to 2022.
  • Outlook Therapeutics, Inc. Depreciation for the quarter ending September 30, 2022 was $40.9K, unchanged year-over-year.
  • Outlook Therapeutics, Inc. Depreciation for the twelve months ending September 30, 2022 was $164K, a 0% increase year-over-year.
  • Outlook Therapeutics, Inc. annual Depreciation for 2022 was $164K, a 0% increase from 2021.
  • Outlook Therapeutics, Inc. annual Depreciation for 2021 was $164K, a 25.4% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $164K +$1.00 +0% Oct 1, 2021 Sep 30, 2022 10-K 2022-12-29
2021 $164K -$55.8K -25.4% Oct 1, 2020 Sep 30, 2021 10-K 2022-12-29
2020 $219K Oct 1, 2019 Sep 30, 2020 10-K 2021-12-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.